Candriam SCA’s Urovant Sciences Ltd. UROV Stock Holding History

Candriam SCA’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-167,787	Closed	-$2.71M	–	825
2020 Q4	$2.71M	Buy	+167,787	New	+$2.08M	0.02%	491

Candriam SCA's UROV Position: Q1 2021 in Review

Candriam SCA sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 167,787 shares — an estimated $2.71M sold.

Candriam SCA first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $2.71M in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Candriam SCA reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Candriam SCA sold 167,787 Urovant Sciences Ltd. shares in Q1 2021, an estimated $2.71M.
Candriam SCA first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
Candriam SCA's Urovant Sciences Ltd. position peaked at $2.71M in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.